References
- Watson W A, Litovitz T L, Rodgers G C, Klein‐Schwartz W, Youniss J, Rose S R, Borys D, May M E. 2002 Annual reports of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med 2003; 21(5)353–423
- Kalkan S, Tuncok Y, Guven H. Poisonings reported to Drug and Poison Information Center, in İzmir, Turkey. J Dokuz Eylul University Fac Med 1998; 12(3)275–283, (In Turkish)
- Liebelt E L, Francis P D. Cyclic antidepressants. Goldfrank's Toxicology Emergencies7th ed, L R Goldfrank, N M Flomenbaum, N A Lewin, M A Howland, R S Hoffman, L S Nelson. McGraw‐Hill Companies, USA 2002; 847–864
- Benowitz N L. Tricylic antidepresants. Poisoning and Drug Overdose3rd ed, K R Olson, , CT 1999; 310–312
- Pentel P R, Wananukul W, Scarlett W, Keyler D E. Nitric oxide contributes to desipramine‐induced hypotension in rats. Hum Exp Toxicol 1996; 15: 320–328
- Tuncok Y, Kalkan S, Murat N, Arkan F, Güven H, Aygören O, Kurt S. The effects of L‐NAME on amitriptyline—induced hypotension in rats. J Toxicol, Clin Toxicol 2002; 40(2)121–127
- Newton E H, Shih R D, Hoffman R S. Cyclic antidepressant overdose: a review of current management strategies. Am J Emerg Med 1994; 12: 376–379
- Harrigan R J, Brady W J. ECG abnormalities in tricyclic antidepressant ingestion. Am J Emerg Med 1999; 17: 387–393
- Belardinelli L, Linden J, Berne R M. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989; 23: 73–97
- Webb R L, Barclay B W, Graybill S C. Cardiovascular effects of adenosine A2a agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands. J Pharmacol Exp Ther 1991; 259: 1203–1212
- Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 1994; 15: 298–306
- Hannon J P, Pfannkuche H J, Fozard J R. A role of mast cell in adenosine A3 receptor‐mediated hypotension in the rats. Br J Pharmacol 1995; 115: 945–952
- Guimaraes S, Albino‐Teixeria A. Hypertension due to chronic blockade of P1‐purinoceptors. J Auton Pharmacol 1996; 16: 367–370
- Guimaraes S, Morato M, Sousa T, Albino‐Teixeria A. Hypertension due to blockade of adenosine receptors. Pharmacol Toxicol 2003; 92: 160–162
- Hannon J P, Pfannkuche H J, Fozard J. A role for mast cell in adenosine A3 receptor‐mediated hypotension in the rat. Br J Pharmacol 1995; 15: 945–952
- Mathot R AA, Van Der Wenden E M, Soudıjn W, Breimer D D, Ijzerman A P, Danhof M. Partial agonism of the nonselective adenosine receptor agonist 8‐Butylaminoadenosine at the A1 receptor in vivo. J Pharmacol Exp Ther 1996; 279: 1439–1446
- Kuan C J, Herzer W A, Jackson E K. Cardiovascular and renal effects of blocking A1 adenosine receptors. J Cardiovasc Pharmacol 1993; 21(5)822–828
- Kamikawa Y, Cline J WH, Su C. Diminished purinergic modulation of vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur J Pharmacol 1980; 66: 347–353
- Kuan C J, Wells J N, Jackson E K. Endogenous adenosine restrains renin release in conscious rats. Circ Res 1990; 66: 637–646